Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: from the 8K just filed

<that should have already been paid back through any subsequent license distributions to TPL (ie PDS should have shorted TPL the balance owed).>

Ah, you made a good point there. If it was just accounting fix between PDS and TPL, it would not require a PTSC 8K. It must involve PTSC.

But going to your statement above. Has there been any distributions to the JV partners by which PDS could have shorted TPL to the tune of 1.1 mil? It seems like ages since PDS made any distribution to the partners. ??????

Opty

Share
New Message
Please login to post a reply